Intensive diabetes management is the process by which blood glucose levels are closely controlled using multiple daily insulin injections or an insulin pump. Intensive Diabetes Management is geared toward the health care practitioner who wants to implement this method in his or her patients. Now in its seventh edition, this authoritative text includes the latest advances in research and therapy. The data, guidelines, and procedures reflect the latest positions of the American Diabetes Association's standards of care. Although difficult to maintain, intensive diabetes management has proven very effective and is now the rule, rather than the exception, in diabetes care. People who use this method of diabetes management must be closely aligned with their health care team and highly motivated because it not only requires close scrutiny of blood glucose levels, but also constant monitoring of food intake and medication dosage, among other things. Virtually all patients with type 1 or type 2 diabetes can improve their glycemic control and overall health through intensive diabetes management. Intensive Diabetes Management emphasizes a team approach to patient care and offers guidance in helping patients move toward treatment goals appropriate for their individual skills and medical condition. Individual sections address all of the key topics in intensive diabetes management, including rationale/physiological basis, team approach, education, pyschosocial issues, patient selection/goals of therapy, insulin regimens, insulin pump therapy, monitoring, and nutrition management.

As type 2 diabetes continues its rise in prevalence worldwide, there is an increasing need to study it and describe successful treatments. There are several options for treatment, including oral medications, diet and lifestyle modification, and insulin therapy. Knowing which method to select and how to apply it relies on several clinical guidelines that are updated every year by the American Diabetes Association. This new edition of Medical Management of Type 2 Diabetes provides care providers with the answers to their questions about implementing care. All of the contributors are experts in their fields, and they define the disease, including the progressive nature of type 2 diabetes; cardiovascular, microvascular, and neurological complications; care methodologies for special situations; and behavior change. All guidelines and standards have been updated with the latest developments in research, advances in medications and medical devices, and new understandings of how to effectively work with the patient.

Diabetes clinical practice is a life-long learning experience, and the insights presented in Diabetes in Practice will facilitate a deeper knowledge of the complex nature of diabetes and its comorbidities for physicians, nurse practitioners, registered dietitians, diabetes educators, and students. Diabetes in Practice offers a deep look into years of the professional practice of clinical diabetes. The 49 case studies Boris Draznin, MD, PhD, has assembled cover a wide array of diabetes cases involving atypical presentations to those addressing ketoacidosis and hypoglycemia, continuous glucose monitoring and insulin pumps, and diabetes co-occurring with cancer and autoimmune conditions. Each case study includes expert review from long-term diabetes practitioners to help you in your daily interactions with patients and enhance your understanding of diabetes diagnosis and treatment challenges.

Type 1 diabetes, formerly known as juvenile diabetes, is a complex disorder that requires a great deal of patient-guided self-care. In recent years, advances in diabetes treatment have dramatically shifted potential outcomes in the favor of the patient with diabetes. The challenge for health care professionals is to realize this potential through an individualized, flexible, and responsive treatment plan for patients with type 1 diabetes. Now in its seventh edition, Medical Management of Type 1 Diabetes offers health care providers the newest information and guidelines for the treatment of type 1 diabetes. Built on the foundation of multiple daily insulin injections and insulin pump therapy, this book guides health care providers in helping their patients continually strive for optimal blood glucose control. This new edition focuses on the latest molecular advances, new treatment methods, recent clinical trials, and the American Diabetes Association's Standards of Care. Key topics also include new insulins and administration protocols, advanced carbohydrate counting, and emphasis on continuing patient education. Individual sections address all of the topics in managing type 1 diabetes, including diagnosis and classification/pathogenesis, diabetes standards and education, tools of therapy, special situations, psychosocial factors affecting adherence, quality of life, and well-being and complications. Medical Management of Type 1 Diabetes is an essential addition to any clinician's library for the treatment and understanding of type 1 diabetes.

The fourth edition of Practical Insulin: A Handbook for Prescribing Providers is a completely revised version of the popular ADA pocket reference. With information on all the currently FDA-approved insulins, this handy pocket guide gives you fast, reliable information and helps you overcome the challenges all clinicians face—choosing an insulin regimen to effectively manage blood glucose and patient resistance. It includes data on all types of insulin, mixing insulins, absorption rates, and more.

In the 5th Edition of this important text, practical, concise information on intensive care is presented in a clear and accessible style. The text covers a broad spectrum of intensive care medicine with enough detail to eliminate the need to refer to a larger reference book. This thoroughly revised and updated edition reflects the best and most current practices from leading international centres.

Cardiovascular, respiratory, and related conditions cause more than 40 percent of all deaths globally, and their substantial burden is rising, particularly in low- and middle-income countries (LMICs). Their burden extends well beyond health effects to include significant economic and societal consequences. Most of these conditions are related, share risk factors, and have common control measures at the clinical, population, and policy levels. Lives can be extended and improved when these diseases are prevented, detected, and managed. This volume summarizes current knowledge and presents evidence-based interventions that are effective, cost-effective, and scalable in LMICs.